Private Advisor Group’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
504,000
+4,300
+0.9% +$12.7K 0.01% 1224
2026
Q1
$1.53M Buy
499,700
+79,900
+19% +$346K 0.01% 1174
2025
Q4
$1.49M Sell
419,800
-35,325
-8% -$216K 0.01% 1172
2025
Q3
$4.05M Buy
455,125
+55,900
+14% +$567K 0.02% 703
2025
Q2
$3.68M Buy
399,225
+184,500
+86% +$1.57M 0.02% 692
2025
Q1
$1.84M Buy
214,725
+184,800
+618% +$1.75M 0.01% 935
2024
Q4
$321K Sell
29,925
-17,488
-37% -$135K ﹤0.01% 1814
2024
Q3
$269K Buy
47,413
+4,442
+10% +$25.6K ﹤0.01% 2018
2024
Q2
$181K Buy
42,971
+46
+0.1% +$186 ﹤0.01% 2172
2024
Q1
$218K Buy
42,925
+1,945
+5% +$10.9K ﹤0.01% 2061
2023
Q4
$382K Sell
40,980
-1,850
-4% -$12.7K ﹤0.01% 1636
2023
Q3
$281K Buy
42,830
+11,150
+35% +$88.7K ﹤0.01% 1663
2023
Q2
$258K Sell
31,680
-7,500
-19% -$64.3K ﹤0.01% 1718
2023
Q1
$336K Sell
39,180
-78,700
-67% -$786K ﹤0.01% 1516
2022
Q4
$1.09K Sell
117,880
-16,800
-12% -$179K ﹤0.01% 1229
2022
Q3
$1.39M Sell
134,680
-51,800
-28% -$547K 0.02% 766
2022
Q2
$1.87M Buy
186,480
+63,225
+51% +$599K 0.02% 787
2022
Q1
$1.52M Buy
+123,255
New +$1.52M 0.01% 915
2020
Q3
Sell
-3,000
Closed -$15K 1712
2020
Q2
$15K Buy
+3,000
New +$11.3K ﹤0.01% 2710

Other funds holding AVXL

Private Advisor Group's AVXL Position: Q2 2026 in Review

Private Advisor Group increased its Anavex Life Sciences (AVXL) stake by 0.86% in Q2 2026, buying an estimated $12.7K and bringing the position to 504,000 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1224.

Private Advisor Group first reported a position in AVXL in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.05M in Q3 2025. 40 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Private Advisor Group held 504,000 shares of Anavex Life Sciences worth $1.31M as of Q2 2026.
  • Private Advisor Group bought 4,300 Anavex Life Sciences shares in Q2 2026, an estimated $12.7K.
  • Anavex Life Sciences made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1224 holding.
  • Private Advisor Group first reported a position in Anavex Life Sciences in Q2 2020 and has held it in 19 quarters since.
  • Private Advisor Group's Anavex Life Sciences position peaked at $4.05M in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.